Drug Type Small molecule drug |
Synonyms AGMB 129, AGMB129, ORG-129 + [1] |
Target |
Action inhibitors |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Phase 2 | United States | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Austria | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Canada | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Denmark | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Germany | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Italy | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Poland | 01 Aug 2023 | |
Crohn Disease | Phase 2 | Spain | 01 Aug 2023 |